Cite
HARVARD Citation
Franek, E. et al. (2022). Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial. Diabetes, obesity & metabolism. 24 (9), pp. 1753-1761. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Franek, E. et al. (2022). Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial. Diabetes, obesity & metabolism. 24 (9), pp. 1753-1761. [Online].